相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis
Silvia Marino et al.
CANCER LETTERS (2017)
RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers
Emma Nolan et al.
NATURE MEDICINE (2016)
Parthenolide inhibits osteoclast differentiation and bone resorbing activity by down-regulation of NFATc1 induction and c-Fos stability, during RANKL-mediated osteoclastogenesis
Ju-Young Kim et al.
BMB REPORTS (2014)
Nuclear factor-κB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells
Kumiko Oida et al.
SCIENTIFIC REPORTS (2014)
Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma
Xiang H. -F. Zhang et al.
CELL (2013)
Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis
John G. Logan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss
Nadia Rucci et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
IKK-β mediates chemoresistance by sequestering FOXO3; A critical factor for cell survival and death
Tugsan Tezil et al.
CELLULAR SIGNALLING (2012)
Breast-Cancer Adjuvant Therapy with Zoledronic Acid
Robert E. Coleman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
IKKβ Regulates the Repair of DNA Double-Strand Breaks Induced by Ionizing Radiation in MCF-7 Breast Cancer Cells
Lixian Wu et al.
PLOS ONE (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
The Biphenyl-Carboxylate Derivative ABD328 is a Novel Orally Active Antiresorptive Agent
Aymen I. Idris et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
Suppression of NF-κB Increases Bone Formation and Ameliorates Osteopenia in Ovariectomized Mice
Neil Alles et al.
ENDOCRINOLOGY (2010)
Small molecule inhibitors of IκB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo
Aymen I. Idris et al.
FASEB JOURNAL (2010)
IKKβ Activation Is Sufficient for RANK-Independent Osteoclast Differentiation and Osteolysis
Jesse E. Otero et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Effects of Denosumab in Patients With Bone Metastases With and Without Previous Bisphosphonate Exposure
Jean-Jacques Body et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Identification of Novel Biphenyl Carboxylic Acid Derivatives as Novel Antiresorptive Agents that Do Not Impair Parathyroid Hormone-Induced Bone Formation
Aymen I. Idris et al.
ENDOCRINOLOGY (2009)
Pharmacologic inhibitors of IκB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo
Aymen I. Idris et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Inhibition of osteoblastic bone formation by nuclear factor-κB
Jia Chang et al.
NATURE MEDICINE (2009)
The IKK-related kinases: from innate immunity to oncogenesis
Jean-Francois Clement et al.
CELL RESEARCH (2008)
The I kappa B kinase - a bridge between inflammation and cancer
Michael Karin
CELL RESEARCH (2008)
Advances in targeting IKK and IKK-related kinases for cancer therapy
Dung-Fang Lee et al.
CLINICAL CANCER RESEARCH (2008)
Targeting NF-κB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth
Michel Jourdan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
Jun-Li Luo et al.
NATURE (2007)
NF-kappa B in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF
Bae Keun Park et al.
NATURE MEDICINE (2007)
Parthenolide, a natural inhibitor of nuclear factor-kappa B, inhibits lung colonization of murine osteosarcoma cells
Yuki Kishida et al.
CLINICAL CANCER RESEARCH (2007)
Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases
V. A. Siclari et al.
CANCER AND METASTASIS REVIEWS (2006)
IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss
MG Ruocco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Crosstalk between cancer cells and bone microenvironment in bone metastasis
T Yoneda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
A novel NF-κB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors
A Tanaka et al.
BLOOD (2005)
Mechanisms of disease: Mechanisms of bone metastasis
GD Roodman
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Osteoclast differentiation is impaired in the absence of inhibitor of κB kinase α
ML Chaisson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A novel IKKβ inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance
J Kamon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
BMS-345541 is a highly selective inhibitor of IκB kinase that binds at an allosteric site of the enzyme and blocks NF-κB-dependent transcription in mice
JR Burke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
RE Coleman
CANCER TREATMENT REVIEWS (2001)
Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis
N Kobayashi et al.
EMBO JOURNAL (2001)
Nitric oxide is a mediator of apoptosis in the rheumatoid joint
RJ van't Hof et al.
RHEUMATOLOGY (2000)
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer
BE Hillner et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
